Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat modeljsm

Journal of Sexual Medicine

Volumn 6, Issue SUPPL. 6, 2009, Pages 738-746

  Qiu, Xuefeng ^a   Lin, Guiting ^a   Xin, Zhongcheng ^b   Ferretti, Ludovic ^a   Zhang, Haiyang ^a   Lue, Tom F ^a   Lin, Ching Shwun ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Diabetes mellitus; Erectile dysfunction; Low energy shockwave

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ERECTILE DYSFUNCTION; EXTRACORPOREAL LITHOTRIPSY; HISTOLOGY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; LOW ENERGY SHOCKWAVE THERAPY; MALE; MESENCHYMAL STEM CELL; NERVE REGENERATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; THERAPY EFFECT;

EID: 84874766863     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12024     Document Type: Article

References (27)

1. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998; 13:159-66.
2. Dorsey P, Keel C, Klavens M, Hellstrom WJ. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother 2010;11:1109-22.
3. Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy-A novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med 2012;9:259-64.
4. Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol 2010;58:243-8.
5. Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol 2012;187:1769- 75.
6. Zimpfer D, Aharinejad S, Holfeld J, Thomas A, Dumfarth J, Rosenhek R, Czerny M, Schaden W, Gmeiner M, Wolner E, Grimm M. Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. J Thorac Cardiovasc Surg 2009;137:963-70.
7. Fu M, Sun CK, Lin YC, Wang CJ, Wu CJ, Ko SF, Chua S, Sheu JJ, Chiang CH, Shao PL, Leu S, Yip HK. Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: Molecular-cellular and functional assessment. PLoS ONE 2011;6:e24342.
8. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, Matsumoto Y, Kajihara N, Eto M, Matsuda T, Yasui H, Takeshita A, Sunagawa K. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004;110:3055-61.
9. Mittermayr R, Hartinger J, Antonic V, Meinl A, Pfeifer S, Stojadinovic A, Schaden W, Redl H. Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Ann Surg 2011;253: 1024-32.
10. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006;114:2823-30.
11. Chen YJ,Wurtz T,Wang CJ, Kuo YR, Yang KD, Huang HC, Wang FS. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res 2004;22:526-34.
12. Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002;167:761-7.
13. Lin CS, Ho HC, Chen KC, Lin G, Nunes L, Lue TF. Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int 2002;89:955- 60.
14. Lin CS, Lue TF. Growth factor therapy and neuronal nitric oxide synthase. Int J Impot Res 2004;16(1 suppl):S38-9.
15. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue TF. Recent advances in andrology-related stem cell research. Asian J Androl 2008;10:171-5.
16. Lin CS, Xin ZC,Wang Z, Deng C, Huang YC, Lin G, Lue TF. Stem cell therapy for erectile dysfunction: A critical review. Stem Cells Dev 2012;21:343-51.
17. Bickenbach JR, Chism E. Selection and extended growth of murine epidermal stem cells in culture. Exp Cell Res 1998; 244:184-95.
18. Lin G, Huang YC, Shindel AW, Banie L, Wang G, Lue TF, Lin CS. Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy 2009;11:864-73.
19. Lin G, Xin Z, Zhang H, Banie L, Wang G, Qiu X, Ning H, Lue TF, Lin CS. Identification of active and quiescent adipose vascular stromal cells. Cytotherapy 2012;14:240-6.
20. Zhang H, Lin G, Qiu X, Ning H, Banie L, Lue TF, Lin CS. Label retaining and stem cell marker expression in the developing rat urinary bladder. Urology 2012;79:746 e1-6.
21. Qiu X, Lin H, Wang Y, Yu W, Chen Y, Wang R, Dai Y. Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocininduced diabetic rats. J Sex Med 2011;8:427-36.
22. Zhou F, Xin H, Liu T, Li GY, Gao ZZ, Liu J, Li WR, Cui WS, Bai GY, Park NC, Xin ZC. Effects of icariside II on improving erectile function in rats with streptozotocininduced diabetes. J Androl 2012;33:832-44.
23. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003;52:2353-62.
24. Dashwood MR, Crump A, Shi-Wen X, Loesch A. Identification of neuronal nitric oxide synthase (nNOS) in human penis: A potential role of reduced neuronally-derived nitric oxide in erectile dysfunction. Curr Pharm Biotechnol 2011;12:1316-21.
25. Thorve VS, Kshirsagar AD, Vyawahare NS, Joshi VS, Ingale KG, Mohite RJ. Diabetes-induced erectile dysfunction: Epidemiology, pathophysiology and management. J Diabetes Complications 2011;25:129-36.
26. Albersen M, Lin G, Fandel TM, Zhang H, Qiu X, Lin CS, Lue TF. Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction. Urology 2011;78:476 e1-8.
27. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 2010;7:445-75.